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Amyloid Ion Channels: A Porous Argument or a Thin Excuse?
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Over the past decade, a number of groups have reported 
that oligomeric intermediates populated during the 
conversion of proteins from a monomeric disaggre-
gated state into amyloid fi  brils can permeabilize lipid 
bilayers and cell membranes. Some of these studies have 
presented electrical current traces that suggest the for-
mation of discrete oligomeric membrane ion channels, 
which exhibit selectivity toward cations that can be 
blocked by a variety of reagents. In this issue, Sokolov 
et al. (p. 637) use carefully prepared oligomers of the 
amyloid-β peptide (Aβ), combined with sensitive cur-
rent measurements capable of detecting the properties 
of single ion channels to examine the effects of the 
oligomers on membrane conductance. They conclude 
that Aβ oligomers clearly cause an increase in mem-
brane permeability, but convincingly rule out any signif-
icant formation of discrete ion channels in their samples. 
Instead, it appears that the oligomers may interfere with 
the surface packing of the lipid headgroups and lead to 
an effective thinning of the membrane, thereby reduc-
ing its effectiveness as a conductance barrier.
The membrane-perturbing activity of amyloid oligo-
mers, whether it is due to channel formation or to 
some other mechanism, would be expected to contrib-
ute   signifi  cantly to amyloid-induced toxicity and may 
  therefore be an appropriate target for the develop-
ment of new therapeutics. Pinning down the precise 
mechanism(s) behind oligomer-mediated membrane 
permeabilization is therefore of paramount importance, 
as strategies to interfere with this activity will   differ 
greatly depending on our understanding of the under-
lying mechanism. If oligomeric membrane-inserted ion 
channels are indeed the culprit, compounds of poten-
tial therapeutic value would include those that block 
the channels or that prevent channel assembly or inser-
tion. If the relevant mechanism of action does not de-
pend on membrane channel insertion but instead 
involves surface interactions that perturb global mem-
brane structure, design targets might include stabilizing 
global membrane structure, preventing oligomer–
  membrane surface interactions, or preventing the for-
mation of soluble oligomers. The work by Sokolov et al. 
(2006) supports the latter approach, but we are left to 
muse upon the origin of the apparent discrepancy be-
tween their results and previous reports citing discrete 
channel formation.
Controversy over the toxicity of amyloidogenic pro-
teins is nothing new. Indeed, the relevance of any as-
pect of protein aggregation to cell death in various 
amyloid diseases was doubted for years and is still ques-
tioned by some (see for example Lee et al., 2004), 
  because the evidence remains indirect. Perhaps the 
strongest argument in favor of a causative role for ag-
gregation comes from genetic studies demonstrating 
that specifi  c proteins that form the ordered fi  brillar ma-
terial in disease-associated amyloid are typically respon-
sible for familial forms of the diseases. The different 
proteins thus implicated do not share any other func-
tional or structural similarities. The only property they 
have in common is their deposition as amyloid fi  brils, 
suggesting that formation of these fi  brils is crucial to 
these proteins’ deleterious effects. In addition, the 
  autosomal dominant nature of many familial forms of 
these disorders, combined with the successful recapitu-
lation of disease phenotypes upon transgenic introduc-
tion of some of the implicated proteins into organisms 
that do not possess naturally occurring homologues, 
implies that a gain of function is likely responsible for 
toxicity in these disorders. Finally, conditions leading to 
excess levels of even the wild-type versions of some of 
the relevant proteins are associated with disease, sug-
gesting a mass action effect, consistent with a crucial 
role for aggregation.
Despite this strong, albeit circumstantial, evidence 
some continue to doubt the “amyloid hypothesis;” these 
doubts are fueled in part by considerable evidence that 
amyloid fi  brils themselves, the mature aggregation end 
product that is observed in diseased tissues, may not be 
directly involved in causing cell damage and death. 
  Indeed, typical amyloid deposits are absent in certain 
forms of disease, and in some cases it appears that even 
when present they do not adversely affect (Tompkins 
and Hill, 1997) and may even favor (Arrasate et al., 
2004) cell survival. These observations, among others, 
have led to the formation of an alternate amyloid hypo-
thesis, sometimes referred to as the oligomer hypothesis, 
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which posits that while mature amyloid fi  brils may not 
be toxic, some species formed during the fi  bril assem-
bly process may be responsible for cell damage. Because 
fi  bril assembly is known to involve oligomeric species, 
these have been proposed as the real culprit (Caughey 
and Lansbury, 2003; Walsh and Selkoe, 2004). The miss-
ing piece of the puzzle, however, remains how these 
oligomers may act.
How might oligomers be toxic to cells? It is instructive 
to fi  rst consider mechanisms that were proposed for 
  fi  bril-mediated toxicity. These include (but are by no 
means limited to) mechanical disruption of cells or tis-
sues, activation of infl  ammatory responses, improper 
activation of signaling pathways, overloading of the pro-
tein degradation machinery, production of oxidative 
species through Fenton type reactions, triggering of un-
folded protein response pathways, and damage to cell 
membranes. Of these mechanisms, only the fi  rst, me-
chanical disruption of cells or tissues is necessarily lim-
ited to the mature fi  brils in amyloid deposits, which, 
unlike oligomers, occupy volumes of the same order of 
magnitude as cells. The remaining proposed mecha-
nisms, as well as others, could just as well apply to amy-
loid oligomers as to amyloid fi  brils. Yet the model that 
has garnered the most attention is that of membrane 
damage. This may be so because of the common adage 
that a picture is worth a thousand words. The case for 
membrane perturbation originally arose in part from 
early reports that the Aβ peptide was able to perturb 
calcium homeostasis in neurons (Hardy and Higgins, 
1992; Mattson et al., 1992). This was followed shortly by 
the fi  rst reports that Aβ was able to form ion channels 
in membranes (Arispe et al., 1993). Subsequently, a 
number of investigators have reported images of amy-
loid oligomers, formed both in the absence and pres-
ence of lipid membranes, that are arranged in toroidal 
shapes (Lashuel and Lansbury, 2006) and appear to re-
semble pore structures similar to those formed by oligo-
meric membrane-lysing toxins such as α-hemolysin 
(Bhakdi and Tranum-Jensen, 1991; Czajkowsky et al., 
1998). Being able to visualize molecular structures with 
an appearance that is consistent with a putative mecha-
nism of toxicity has generated considerable excitement 
for the so-called channel hypothesis.
While the idea that polypeptides having arbitrary se-
quences are capable of forming discrete membrane 
channel structures may seem farfetched, it is important 
to note that the same collection of apparently arbitrary 
proteins already is known to assembly into a common 
highly ordered structure (O’Nuallain and Wetzel, 
2002), namely the mature amyloid fi  bril. In addition, 
recent work has suggested that amyloid oligomers are 
also generic, both structurally (Kayed et al., 2003) and 
functionally (Bucciantini et al., 2002; Kayed et al., 2004). 
Nevertheless, there is little evidence at present to di-
rectly link the imaged annular structures with mem-
brane channel activity. Indeed, in only a few instances 
were current records indicative of channel formation 
and images of channel-like structures recorded on 
equivalent preparations (Lin et al. 2001; Quist et al. 
2005), and in these cases the large number of imaged 
“channels” appears to be inconsistent with observations 
in the current traces of single channel events. As pointed 
out by Sokolov et al., a litmus test for confi  rming the 
relevance of single channel observations is that they 
successfully predict the conductance properties of bulk 
membranes containing large numbers of channels. 
These tests have yet to be performed for amyloid ion 
channels. For example, discrete amyloid ion channels 
appear be gated by voltage, but the ensemble voltage 
dependence of currents in bulk samples, which should 
be predictable from the single channel data, has not 
been examined. Similarly, currents from individual am-
yloid channels can be blocked by various reagents, but 
corresponding blockage of conductance in bulk sam-
ples remains to be shown.
Despite these points, there is ample evidence for dis-
crete amyloid-induced current changes across mem-
branes, yet such signals were not observed by Sokolov 
et al. A potential explanation may involve the notorious 
dependence of Aβ behavior on experimental condi-
tions. Early on in studies of Aβ aggregation it was noted 
that different preparations of the peptide exhibited dif-
ferent aggregation kinetics (Soto et al. 1995), and the 
peptide consequently developed a reputation for being 
diffi  cult to work with. Some degree of consensus now 
exists that dissolution of lyophilized Aβ in organic sol-
vents such as DMSO or HFIP results in aggregate-free 
starting material. This is the approach used by Sokolov 
et al., who have gone to considerable trouble to develop 
protocols that lead to uniform and reproducible oligo-
mer preparations (Kayed et al. 2004). In their experi-
ments, the preformed oligomers are added to the 
solutions bathing the preformed lipid bilayer. On 
the other hand, dissolution in double-distilled H2O 
(ddH2O) is also commonly used to prepare monomeric 
Aβ, although this method may not be as effective at dis-
assembling aggregates present in the lyophilized mate-
rial. In reports that document Aβ ion channel currents, 
the preparation method typically involves dissolution of 
the peptide in ddH2O. Dissolved monomeric peptides 
are then either added to the solutions bathing pre-
formed lipid bilayers or are sonicated in the presence of 
lipids to form proteoliposomes, which are then fused 
into lipid planar bilayers. It is perhaps not surprising 
that these rather different methods of sample prepa-
rations lead to different results. It may well be that 
  channel formation, which is characterized by stable 
membrane insertion, is facilitated by sonication of pro-
tein–lipid mixtures, whereas membrane insertion of 
aqueously soluble oligomers may be diffi  cult. Further-
more, membrane surfaces are known to nucleate the   Eliezer 633
aggregation of monomeric Aβ (Yip et al. 2002), but how 
oligomers formed during lipid-induced aggregation 
compare to those formed in solution is not known. 
  Despite some similarity between images of annular 
structures obtained in aqueous solutions and in mem-
branes, it may well be that soluble oligomers are ar-
ranged quite differently from channel-forming, 
membrane-inserted oligomers. Indeed, it is now known 
that mature amyloid fi  brils themselves exist in structur-
ally distinct forms   (Petkova et al. 2005) and different 
forms of amyloid oligomers may therefore also be ex-
pected to exist.
Sokolov et al. have shown that soluble Aβ oligomers 
permeabilize lipid membranes by altering their bulk elec-
trophysiological properties and effectively thinning the 
insulating barrier they present to conductance. Reconcil-
ing their results with previous demonstrations of discrete 
ion channel formation by Aβ will require careful work to 
analyze the contribution of discrete channels to bulk con-
ductance, as well as to characterize the relation between 
the pathways leading to soluble oligomers and to the for-
mation of channels. Both effects may be expected to play 
an important role in disease, and establishing these roles 
will require in vivo studies guided by knowledge obtained 
from biophysical studies of the underlying mechanisms. 
Intervention efforts targeting the two different effects 
may require signifi  cantly different strategies.
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